Regarding the role of copeptin as a prognostic blood biomarker following a TIA, Greisenegger et al. [39] having enrolled 1076 patients presented with ischemic stroke or TIA observed that copeptin has the potential not only to forecast the long-term risk of recurrent vascular events and ischemic stroke but also to be predictive of vascular and all-cause death after TIA or stroke. Here, AVP is linked to transient ischemic attack.